This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Aug;36(3):293; discussion 294.

doi: 10.1111/j.1365-2036.2012.05168.x.

Commentary: new tools to assess hepatic steatosis--what do we want to measure?

Z Yu¹, V W-S Wong

Affiliations

PMID: 22747453
DOI: 10.1111/j.1365-2036.2012.05168.x

Comment

Commentary: new tools to assess hepatic steatosis--what do we want to measure?

Z Yu et al. Aliment Pharmacol Ther. 2012 Aug.

. 2012 Aug;36(3):293; discussion 294.

doi: 10.1111/j.1365-2036.2012.05168.x.

Authors

Z Yu¹, V W-S Wong

Affiliation

¹ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

PMID: 22747453
DOI: 10.1111/j.1365-2036.2012.05168.x

No abstract available

PubMed Disclaimer

Comment on

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.
Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, Loomba R. Permutt Z, et al. Aliment Pharmacol Ther. 2012 Jul;36(1):22-9. doi: 10.1111/j.1365-2036.2012.05121.x. Epub 2012 May 3. Aliment Pharmacol Ther. 2012. PMID: 22554256 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information